Healthcare Realty Trust Reports Results For the Third Quarter

Rhea-AI Summary

Healthcare Realty Trust reported Q3 2024 results with a net loss of $(93.0) million, or $(0.26) per share. Key highlights include Normalized FFO per share of $0.39, up 1.2% year-over-year. The company secured $875 million from joint venture and asset sales through October, with $447 million in share repurchases. Multi-tenant absorption reached 159,000 square feet, with occupancy at 86.5%. Same Store cash NOI increased 3.1% year-over-year, with tenant retention at 80.5%. The company maintained its quarterly dividend at $0.31 per share and updated its 2024 Normalized FFO guidance to $1.55-$1.56 per share.

Positive

• Normalized FFO per share increased 1.2% year-over-year to $0.39
• Generated $875 million from joint venture and asset sales
• Same Store cash NOI grew 3.1% year-over-year
• Multi-tenant occupancy improved 164 basis points over trailing twelve months
• Operating expenses decreased 1.5% compared to prior year quarter

Negative

• Net loss of $93.0 million or $(0.26) per share
• Multi-tenant occupancy remains relatively low at 86.5%
• Lowered high end of 2024 Normalized FFO guidance from $1.58 to $1.56

Insights

Financial Analyst

Healthcare Realty Trust's Q3 results reveal mixed performance with notable developments. The $93.0 million net loss translates to $(0.26) per share, though normalized FFO showed slight improvement at $0.39 per share. The company's strategic capital allocation through $875 million in JV and asset sales demonstrates active portfolio optimization.

Key positives include 3.1% same-store cash NOI growth and strong leasing momentum with 431,000 square feet of new leases. The 86.5% multi-tenant occupancy rate shows steady improvement, up 164 basis points year-over-year. However, leverage remains elevated at 6.7x net debt to adjusted EBITDA, though expected to improve to 6.5x by year-end.

The revised guidance suggesting normalized FFO of $1.55 to $1.56 per share indicates stable operational performance despite market challenges. The maintained quarterly dividend of $0.31 per share reflects management's confidence in cash flow stability.

NASHVILLE, Tenn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the third quarter ended September 30, 2024. Net (loss) income attributable to common stockholders for the three months ended September 30, 2024 was $(93.0) million, or $(0.26) per diluted common share.

KEY THIRD QUARTER HIGHLIGHTS

• Normalized FFO per share of $0.39, up 1.2% over the prior year period
• $875 million of proceeds from JV and asset sale transactions through October
• $447 million of share repurchases year-to-date through October
• 159,000 square feet, or 49 basis points, of multi-tenant absorption
• 431,000 square feet of signed new leases in the quarter, the fifth consecutive quarter above 400,000
  

CAPITAL ALLOCATION

• The Company closed joint venture and asset sale transactions since the second quarter totaling $478 million bringing proceeds to approximately $875 million through October, which includes the following:
  • $522 million from joint venture transactions
  • $353 million from asset sales
• The Company has additional transactions under contract and letters of intent that are expected to increase proceeds to approximately $1.1 billion for the year.
• Through October, the Company has repurchased 27.1 million shares totaling $446.8 million at an average price of $16.48 per share.

MULTI-TENANT OCCUPANCY AND ABSORPTION

• Multi-tenant sequential occupancy gains continue to track towards full year 2024 expectations provided in the February 2024 Investor Presentation as shown below:
  

		3Q 2024	YTD 2024
	Absorption (SF)	158,720	341,473
	Change in occupancy (bps)	+ 49	+ 106

• The multi-tenant portfolio occupancy rate was 86.5% and the leased percentage was 87.8% at September 30.
• Multi-tenant occupancy has increased by 164 basis points over the trailing-twelve-month period. For the Legacy HTA properties, multi-tenant occupancy has increased by 230 basis points for the same period.
• An updated multi-tenant occupancy and NOI bridge can be found on page 5 of the Key Highlights Investor Presentation located on the Company's website.

LEASING

• Portfolio leasing activity that commenced in the third quarter totaled 1,641,000 square feet related to 455 leases:
  • 1,054,000 square feet of renewals
  • 587,000 square feet of new and expansion lease commencements
• The Company signed new leases totaling 431,000 square feet in the quarter, the fifth consecutive quarter above 400,000.
  

SAME STORE

• Same Store cash NOI for the third quarter increased 3.1% over the same quarter in the prior year.
• Tenant retention for the third quarter was 80.5%.
• Operating expenses decreased 1.5% over the same quarter in the prior year.
• Third quarter predictive growth measures in the Same Store portfolio include:
  • Average in-place rent increases of 2.8%.
  • Future annual contractual increases of 3.1% for leases commencing in the quarter.
  • Weighted average MOB cash leasing spreads of 3.9% on 847,000 square feet renewed:
    • 7% (<0% spread)
    • 7% (0-3%)
    • 58% (3-4%)
    • 28% (>4%)

BALANCE SHEET

• As of September 30, 2024, net debt to adjusted EBITDA was 6.7 times. Net debt to adjusted EBITDA is expected to be 6.5 times at the end of the year.
• In October, the Company repaid the remaining $100 million outstanding of Unsecured Term Loan maturing July 2025.
• As of September 30, 2024, the Company had approximately $1.3 billion of availability under its credit facility.

DIVIDEND

• A dividend of $0.31 per share was paid in August 2024. A dividend of $0.31 per share will be paid on November 27, 2024 to stockholders and OP unitholders of record on November 12, 2024.

GUIDANCE

• The Company's 2024 per share guidance ranges are as follows:
  
  

									EXPECTED 2024
		ACTUAL							PRIOR							CURRENT
		3Q 2024			YTD				LOW			HIGH				LOW			HIGH
	Earnings per share	$	(0.26	)	$	(1.49	)		$	(1.50	)	$	(1.40	)		$	(1.60	)	$	(1.59	)
	NAREIT FFO per share	$	0.21		$	0.23			$	0.77		$	0.82			$	0.58		$	0.59
	Normalized FFO per share	$	0.39		$	1.16			$	1.53		$	1.58			$	1.55		$	1.56

• The Company's 2024 guidance range includes activities outlined in the Components of Expected FFO on page 29 of the Supplemental Information.
  

The 2024 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from
dispositions, potential impairments, or debt extinguishment costs, if any. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results vary from these assumptions, the Company's expectations may change.

EARNINGS CALL

• On Wednesday, October 30, 2024, at 11:00 a.m. Eastern Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.
• Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address.
• Live Conference Call Access Details:
  • Domestic Toll-Free Number: +1 404-975-4839 access code 470628;
  • All Other Locations: +1 833-470-1428 access code 470628.
• Replay Information:
  • Domestic Toll-Free Number: +1 929-458-6194 access code 780754;
  • All Other Locations: +1 866-813-9403 access code 780754.

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes over 650 properties totaling nearly 40 million square feet concentrated in 15 growth markets.

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: the Company's expected results may not be achieved; failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2023 Annual Report on Form 10-K and in its other filings with the SEC.

Consolidated Balance Sheets

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

ASSETS
	3Q 2024			2Q 2024			1Q 2024			4Q 2023			3Q 2023
Real estate properties
Land	$	1,195,116		$	1,287,532		$	1,342,895		$	1,343,265		$	1,387,821
Buildings and improvements		10,074,504			10,436,218			10,902,835			10,881,373			11,004,195
Lease intangibles		718,343			764,730			816,303			836,302			890,273
Personal property		9,246			12,501			12,720			12,718			12,686
Investment in financing receivables, net		123,045			122,413			122,001			122,602			120,975
Financing lease right-of-use assets		77,728			81,401			81,805			82,209			82,613
Construction in progress		125,944			97,732			70,651			60,727			85,644
Land held for development		52,408			59,871			59,871			59,871			59,871
Total real estate investments		12,376,334			12,862,398			13,409,081			13,399,067			13,644,078
Less accumulated depreciation and amortization		(2,478,544	)		(2,427,709	)		(2,374,047	)		(2,226,853	)		(2,093,952	)
Total real estate investments, net		9,897,790			10,434,689			11,035,034			11,172,214			11,550,126
Cash and cash equivalents1		22,801			137,773			26,172			25,699			24,668
Assets held for sale, net		156,218			34,530			30,968			8,834			57,638
Operating lease right-of-use assets		259,013			261,976			273,949			275,975			323,759
Investments in unconsolidated joint ventures		417,084			374,841			309,754			311,511			325,453
Other assets, net and goodwill		491,679			559,818			605,047			842,898			822,084
Total assets	$	11,244,585		$	11,803,627		$	12,280,924		$	12,637,131		$	13,103,728
LIABILITIES AND STOCKHOLDERS' EQUITY
	3Q 2024			2Q 2024			1Q 2024			4Q 2023			3Q 2023
Liabilities
Notes and bonds payable	$	4,957,796		$	5,148,153		$	5,108,279		$	4,994,859		$	5,227,413
Accounts payable and accrued liabilities		197,428			195,884			163,172			211,994			204,947
Liabilities of properties held for sale		7,919			1,805			700			295			3,814
Operating lease liabilities		229,925			230,601			229,223			229,714			273,319
Financing lease liabilities		71,887			75,199			74,769			74,503			74,087
Other liabilities		180,283			177,293			197,763			202,984			211,365
Total liabilities		5,645,238			5,828,935			5,773,906			5,714,349			5,994,945
Redeemable non-controlling interests		3,875			3,875			3,880			3,868			3,195
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized		—			—			—			—			—
Common stock, $0.01 par value; 1,000,000 shares authorized		3,558			3,643			3,815			3,810			3,809
Additional paid-in capital		9,198,004			9,340,028			9,609,530			9,602,592			9,597,629
Accumulated other comprehensive (loss) income		(16,963	)		6,986			4,791			(10,741	)		17,079
Cumulative net income attributable to common stockholders		481,155			574,178			717,958			1,028,794			1,069,327
Cumulative dividends		(4,150,328	)		(4,037,693	)		(3,920,199	)		(3,801,793	)		(3,684,144	)
Total stockholders' equity		5,515,426			5,887,142			6,415,895			6,822,662			7,003,700
Non-controlling interest		80,046			83,675			87,243			96,252			101,888
Total Equity		5,595,472			5,970,817			6,503,138			6,918,914			7,105,588
Total liabilities and stockholders' equity	$	11,244,585		$	11,803,627		$	12,280,924		$	12,637,131		$	13,103,728

1	2Q 2024 cash and cash equivalents includes $96.0 million of proceeds held in a cash escrow account from a portfolio disposition that closed on June 28, 2024 and was received by the Company on July 1, 2024.

Consolidated Statements of Income

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

	3Q 2024			2Q 2024			1Q 2024			4Q 2023			3Q 2023
Revenues
Rental income 1	$	306,499		$	308,135		$	318,076		$	322,076		$	333,335
Interest income		3,904			3,865			4,538			4,422			4,264
Other operating		5,020			4,322			4,191			3,943			4,661
		315,423			316,322			326,805			330,441			342,260
Expenses
Property operating		120,232			117,719			121,078			121,362			131,639
General and administrative		20,124			14,002			14,787			14,609			13,396
Normalizing items 2		(6,861	)		—			—			(1,445	)		—
Normalized general and administrative		13,263			14,002			14,787			13,164			13,396
Transaction costs		719			431			395			301			769
Merger-related costs		—			—			—			1,414			7,450
Depreciation and amortization		163,226			173,477			178,119			180,049			182,989
		304,301			305,629			314,379			317,735			336,243
Other income (expense)
Interest expense before merger-related fair value		(50,465	)		(52,393	)		(50,949	)		(52,387	)		(55,637	)
Merger-related fair value adjustment		(10,184	)		(10,064	)		(10,105	)		(10,800	)		(10,667	)
Interest expense		(60,649	)		(62,457	)		(61,054	)		(63,187	)		(66,304	)
Gain on sales of real estate properties and other assets		39,310			38,338			22			20,573			48,811
Gain on extinguishment of debt		—			—			—			—			62
Impairment of real estate assets and credit loss reserves		(84,394	)		(132,118	)		(15,937	)		(11,403	)		(56,873	)
Impairment of goodwill		—			—			(250,530	)		—			—
Equity income (loss) from unconsolidated joint ventures		208			(146	)		(422	)		(430	)		(456	)
Interest and other (expense) income, net		(132	)		(248	)		275			65			139
		(105,657	)		(156,631	)		(327,646	)		(54,382	)		(74,621	)
Net (loss) income	$	(94,535	)	$	(145,938	)	$	(315,220	)	$	(41,676	)	$	(68,604	)
Net loss (income) attributable to non-controlling interests		1,512			2,158			4,384			1,143			760
Net (loss) income attributable to common stockholders	$	(93,023	)	$	(143,780	)	$	(310,836	)	$	(40,533	)	$	(67,844	)
Basic earnings per common share	$	(0.26	)	$	(0.39	)	$	(0.82	)	$	(0.11	)	$	(0.18	)
Diluted earnings per common share	$	(0.26	)	$	(0.39	)	$	(0.82	)	$	(0.11	)	$	(0.18	)
Weighted average common shares outstanding - basic		358,960			372,477			379,455			379,044			378,925
Weighted average common shares outstanding - diluted 3		358,960			372,477			379,455			379,044			378,925

1	In 2Q 2024, rental income was reduced by $3.0 million for Steward Health revenue reserves. This consisted of $2.2 million for April and prepetition rent for May as well as $0.8 million for March. In addition, the Company reversed $2.2 million of straight-line rent receivable against rental income.
2	3Q 2024 and 4Q 2023 normalizing items primarily include severance-related costs.
3	Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the outstanding limited partnership units in the Company's operating partnership ("OP"), totaling 3,649,637 units were not included.

Reconciliation of FFO, Normalized FFO and FAD 1,2,3

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

	3Q 2024			2Q 2024			1Q 2024			4Q 2023			3Q 2023
Net loss attributable to common stockholders	$	(93,023	)	$	(143,780	)	$	(310,836	)	$	(40,533	)	$	(67,844	)
Net loss attributable to common stockholders/diluted share3	$	(0.26	)	$	(0.39	)	$	(0.82	)	$	(0.11	)	$	(0.18	)
Gain on sales of real estate assets		(39,148	)		(33,431	)		(22	)		(20,573	)		(48,811	)
Impairments of real estate assets		37,632			120,917			15,937			11,403			56,873
Real estate depreciation and amortization		167,821			177,350			181,161			182,272			185,143
Non-controlling loss from operating partnership units		(1,372	)		(2,077	)		(4,278	)		(491	)		(841	)
Unconsolidated JV depreciation and amortization		5,378			4,818			4,568			4,442			4,421
FFO adjustments	$	170,311		$	267,577		$	197,366		$	177,053		$	196,785
FFO adjustments per common share - diluted	$	0.47		$	0.71		$	0.51		$	0.46		$	0.51
FFO	$	77,288		$	123,797		$	(113,470	)	$	136,520		$	128,941
FFO per common share - diluted4	$	0.21		$	0.33		$	(0.30	)	$	0.36		$	0.34
Transaction costs		719			431			395			301			769
Merger-related costs		—			—			—			1,414			7,450
Lease intangible amortization		(10	)		129			175			261			213
Non-routine legal costs/forfeited earnest money received		306			465			—			(100	)		—
Debt financing costs		—			—			—			—			(62	)
Restructuring and severance-related charges		6,861			—			—			1,445			—
Credit losses and gains on other assets, net5		46,600			8,525			—			—			—
Impairment of goodwill		—			—			250,530			—			—
Merger-related fair value adjustment		10,184			10,064			10,105			10,800			10,667
Unconsolidated JV normalizing items6		101			89			87			89			90
Normalized FFO adjustments	$	64,761		$	19,703		$	261,292		$	14,210		$	19,127
Normalized FFO adjustments per common share - diluted	$	0.18		$	0.05		$	0.68		$	0.04		$	0.05
Normalized FFO	$	142,049		$	143,500		$	147,822		$	150,730		$	148,068
Normalized FFO per common share - diluted	$	0.39		$	0.38		$	0.39		$	0.39		$	0.39
Non-real estate depreciation and amortization		276			313			485			685			475
Non-cash interest amortization, net7		1,319			1,267			1,277			1,265			1,402
Rent reserves, net8		(27	)		1,261			(151	)		1,404			442
Straight-line rent income, net		(5,771	)		(6,799	)		(7,633	)		(7,872	)		(8,470	)
Stock-based compensation		4,064			3,383			3,562			3,566			2,556
Unconsolidated JV non-cash items9		(376	)		(148	)		(122	)		(206	)		(231	)
Normalized FFO adjusted for non-cash items		141,534			142,777			145,240			149,572			144,242
2nd generation TI		(16,951	)		(12,287	)		(20,204	)		(18,715	)		(21,248	)
Leasing commissions paid		(10,266	)		(10,012	)		(15,215	)		(14,978	)		(8,907	)
Building capital		(7,389	)		(12,835	)		(5,363	)		(17,393	)		(14,354	)
Total maintenance capex		(34,606	)		(35,134	)		(40,782	)		(51,086	)		(44,509	)
FAD	$	106,928		$	107,643		$	104,458		$	98,486		$	99,733
Quarterly/dividends and OP distributions	$	113,770		$	118,627		$	119,541		$	118,897		$	119,456
FFO wtd avg common shares outstanding - diluted10		363,370			376,556			383,413			383,326			383,428

1	Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”
2	FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
3	Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.
4	For 1Q 2024, basic weighted average common shares outstanding was the denominator used in the per share calculation.
5	3Q 2024 includes $46.8 million of credit loss reserves and $0.2 million gain on other assets. 2Q 2024 includes $11.2 million of credit loss reserves and $2.2 million write-off of prior period Steward Health straight-line rent, offset by $4.9 million gain on other assets.
6	Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
7	Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
8	2Q 2024 includes $0.8 million related to the Steward Health revenue reserve for March.
9	Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
10	The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 760,552 for the three months ended September 30, 2024. Also includes the diluted impact of 3,649,637 OP units outstanding.

Reconciliation of Non-GAAP Measures

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, and funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income and less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.

Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290

FAQ

What was Healthcare Realty Trust's (HR) Q3 2024 net income?

Healthcare Realty Trust reported a net loss of $(93.0) million, or $(0.26) per diluted common share for Q3 2024.

How much did Healthcare Realty Trust (HR) generate from asset sales in 2024?

The company generated $875 million in proceeds from joint venture and asset sale transactions through October 2024, including $522 million from joint ventures and $353 million from asset sales.

What is Healthcare Realty Trust's (HR) dividend for Q3 2024?

Healthcare Realty Trust declared a dividend of $0.31 per share, to be paid on November 27, 2024 to stockholders of record on November 12, 2024.

What is Healthcare Realty Trust's (HR) updated FFO guidance for 2024?

The company updated its 2024 Normalized FFO guidance to $1.55-$1.56 per share.